The American College of Cardiology’s 71st Annual Scientific Session & Expo
April 2–4, 2022 | Washington, DC
April 2022
ACC.22 provides an engaging and interactive forum where attendees can learn about the latest science and innovation from top experts and colleagues, and get the latest practice-changing updates in cardiovascular care.
Look out for the latest cardiovascular research from Carelon Research at ACC.22. Registration is required to view presentations. For more information, go to accscientificsession.acc.org .
Carelon Research presentations
Carelon Research authors are indicated in bold.
|
Presentation |
Session |
Title |
Authors |
Affiliations |
|---|---|---|---|---|
|
Poster Presentation Saturday, April 2, 2022 |
Session 1195 – Pulmonary vascular disease: clinical and population science digital presentations |
1195-002 / 2 | Real-world perspective: treatment patterns, healthcare resource utilization, and costs among patients with pulmonary arterial hypertension in the United States |
Lia N. Pizzicato1, Vijay R. Nadipelli2, Samuel Governor1, Jianbin Mao2, Stephan Lanes1, John Butler2, Rebecca S. Pepe1, Hemant Phatak2, Karim El-Kersh3 |
1Carelon Research, Wilmington, DE, 2Acceleron Pharma Inc., a wholly owned subsidiary of Merck Sharp & Dohme Corp., Cambridge, MA, 3University of Nebraska Medical Center, Omaha, NE |
|
Poster Presentation Monday, April 4, 2022 |
Session 2004 – Spotlight on Special Topics: Cardio-oncology 13 |
2004-129 / 129 – Risk of venous thromboembolism in patients on first line of therapy for advanced non-small cell lung cancer: a comparison of immune checkpoint inhibitors and chemotherapy regimens |
Alok A. Khorana1, Lisa Rosenblatt2, Radhika Pisupati2, Chi Nguyen3, John Barron3, Kerrin Gallagher3, Jennell Palaia2, T. Christopher Bond2 |
1Cleveland Clinic, Cleveland, OH; 2Bristol Myers Squibb, New York, NY; 3Carelon Research, Wilmington, DE |
